IRF5 and hepatocellular carcinoma: Moreover, our in vivo results were consistent with the findings in vitro, confirming the suppressive effects of SS on HCC HepG2 tumor growth and regulations of CCAT1, miR-375-3p, SP1, and IRF5 expressions.